MAB3262F
Anti-BrdU Antibody, clone PRB-1, FITC conjugated
clone PRB-1, Chemicon®, from mouse
Synonym(e):
BrdU
Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(1)
About This Item
UNSPSC-Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Empfohlene Produkte
Biologische Quelle
mouse
Qualitätsniveau
Konjugat
FITC conjugate
Antikörperform
purified immunoglobulin
Antikörper-Produkttyp
primary antibodies
Klon
PRB-1, monoclonal
Speziesreaktivität (Voraussage durch Homologie)
all
Hersteller/Markenname
Chemicon®
Methode(n)
flow cytometry: suitable
Isotyp
IgG1
Versandbedingung
wet ice
Posttranslationale Modifikation Target
unmodified
Spezifität
Recognizes BrdU in ssDNA, free BrdU or BrdU coupled to a protein carrier. MAB3262 also reacts with iodouridine. Does not react with thymidine.
Immunogen
Iodouridine conjugated to ovalbumin.
Anwendung
Research Category
Epigenetik & nukleäre Funktionen
Epigenetik & nukleäre Funktionen
Research Sub Category
Zellzyklus, DNA-Replikation & -Reparatur
Zellzyklus, DNA-Replikation & -Reparatur
Anti-BrdU Antibody, clone PRB-1, FITC conjugated is a Mouse Monoclonal Antibody for detection of Bromodeoxyuridine also known as BrdU & has been validated in FC.
Flow cytometry: 1:20
Optimal working dilutions must be determined by the end user.
Optimal working dilutions must be determined by the end user.
Physikalische Form
Purified immunoglobulin conjugated to fluorescein. Liquid in PBS with 0.05% sodium azide pH 7.4
Lagerung und Haltbarkeit
Maintain at 2-8°C in undiluted aliquots up to 6 months. Protect from prolonged exposure to light.
Sonstige Hinweise
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Rechtliche Hinweise
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Haftungsausschluss
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Sie haben nicht das passende Produkt gefunden?
Probieren Sie unser Produkt-Auswahlhilfe. aus.
Lagerklassenschlüssel
12 - Non Combustible Liquids
WGK
WGK 2
Flammpunkt (°F)
Not applicable
Flammpunkt (°C)
Not applicable
Analysenzertifikate (COA)
Suchen Sie nach Analysenzertifikate (COA), indem Sie die Lot-/Chargennummer des Produkts eingeben. Lot- und Chargennummern sind auf dem Produktetikett hinter den Wörtern ‘Lot’ oder ‘Batch’ (Lot oder Charge) zu finden.
Besitzen Sie dieses Produkt bereits?
In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.
Kunden haben sich ebenfalls angesehen
CCN1 induces hepatic ductular reaction through integrin ?v??-mediated activation of NF-?B.
Kim, KH; Chen, CC; Alpini, G; Lau, LF
The Journal of Clinical Investigation null
Maria Plesa et al.
Journal of asthma and allergy, 13, 249-264 (2020-09-29)
Airway fibroblasts are major contributors to the histopathological feature of airway remodeling in asthma by their implication in the cell invasiveness and profibrogenic secretory phenotype observed in subepithelial fibrosis. 1,25 Dihydroxy vitamin D3 (1,25(OH)2D3) is an important therapeutic agent that
Himanshu Arora et al.
Journal of stem cells & regenerative medicine, 17(1), 18-27 (2021-08-27)
Rationale: Cardiac sympathetic nerves are required for endogenous repair of the mammalian neonatal heart in vivo, but the underlying mechanism is unclear. Objective: We tested the hypothesis that a combination of cardiac developmental growth factors Wnt3a, BMP4 and Neuregulin (NRG-1)
Johana M Susanto et al.
International journal of oncology, 46(5), 2223-2230 (2015-02-20)
Despite incremental advances in the diagnosis and treatment for pancreatic cancer (PC), the 5‑year survival rate remains <5%. Novel therapies to increase survival and quality of life for PC patients are desperately needed. Epigenetic thera-peutic agents such as histone deacetylase
Songyu Li et al.
Cell death & disease, 11(4), 219-219 (2020-04-07)
DNA damage results in mutations and plays critical roles in cancer development, progression, and treatment. Targeting DNA damage response in cancers by inhibiting poly-(ADP-ribose) polymerases (PARPs) offers an important therapeutic strategy. However, the failure of PARP inhibitors to markedly benefit
Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..
Setzen Sie sich mit dem technischen Dienst in Verbindung.